Treating PCOS with Semaglutide vs Active Lifestyle Intervention (TEAL Study)
The study consists of an initial study visit to determine eligibility, 2 inpatient visits (one prior to starting treatment and one at the end of the 4 month treatment intervention), and one short visit midway between the study.
Child to Adult
12-21 year old girls/young women with PCOS (polycystic ovary syndrome) Cannot be taking metformin or hormonal contraception (as well as other medications that lower blood sugars) Cannot have diabetes Cannot be doing more than 2 hours of physical activity per week.
Contact our study team to see if you're eligible to participate in our study.
Treatment
Childrens Hospital Colorado
Outpatient CTRC
University of Colorado Hospital
Melanie Green, MD, PhD
Protocol Number: 19-0636
More information available at ClinicalTrials.gov: NCT03919929
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers